Scientific Programs

Home / Scientific Programs

Day 1 : Workshop
Friday, February 21, 2025

TIME (GMT+7) Workshop 1 Workshop 2 Workshop 3
08.00-14.30 Targeted Hypertension Care : Tailoring Treatment Across Multiple Conditions
Chair: Tities Anggraeni Indra, MD
Challenges in hypertension : How to session
Chair: Cep Juli, MD
Workshop of Hypertension By Omron Academy
Chair: Rarsari Soerarso Pratikto, MD
08:00 - 08:30 Registration Registration Registration
08:30 - 08:40 Pre Test Pre Test Pre Test
08:40 - 09:00 Hypertension in High Risk Occupation
Made Junior Rina Artha
How to optimize hypertension outcomes with home blood pressure monitoring
Triwedia Indradewi
09:00 - 09:30 Hypertension and Sport : Balancing Fitness and Safety
Ade Median Ambari
How to identify and diagnose secondary hypertension in young adults
Widodo
How to Assess Blood Pressure Variability
Rarsari Soerarso Pratikto
09:30 - 10:00 Comprehensive Strategies in Managing Obesity Related Hypertension
Yulia Sofiatin
Hypertension - Induced Cerebral Small Vessel Disease: How to Manage?
Paulus Anam Ong
The Impact of Morning Blood Pressure Surge in Cerebrovascular Disease
Eka Harmeiwaty
10:00 - 10:15 Coffee Break Coffee Break Coffee Break
10:15 - 10:45 Managing Hypertension in the Elderly : Promoting Healthy Aging
Abdul Wahid
How to manage masked hypertension : a comprehensive approach
Chandra Irwanadi Mohani
Home Blood Pressure Variability: Risk Prediction for Cardiovascular Disease
Badai Tiksnadi
10:45 - 11:15 Treatment of Hypertension in Coronary Artery Disease
A. Sari S. Mumpuni
Hypertension mediated organ damage : how to assess and intervene
Marihot Tambunan
How to Manage Blood Pressure in Chronic Kidney Disease
Nyoman Paramita Ayu
11:15 - 11:30 Q&A Q&A Q&A
11:30 - 13:00 Friday Praying & Lunch Friday Praying & Lunch Friday Praying & Lunch
13:00 - 13:30 Interactive Case Discussion
Dimas Septiar
Interactive case discussion
Oryza Gryagus
Hands on by OMRON
13:30 - 14:30 Interactive case discussion : Management of Hypertension in Multiple Organ Damage
Eka Harmeiwaty
14:30 - 14:40

Day 2 : Symposium
Saturday, February 22, 2025

TIME (GMT+7) Ballroom 1 Ballroom 2 Ballroom 3
07.50-08.00 Ethical Issues in Managing Hypertension
Pukovisa Prawiroharjo
08.00-08.40 Morning Talks On Hypertension
Zulkhair Ali
08.00 - 08.10 Resistant Hypertension: A Practical Clinical Approach for Diagnosis and Treatment
Interactive Case Study 1: Resistant Hypertension
Case Presenter: Anandhara Indriani K
Panelists: Sari Mumpuni, Chandra Irawadi M, Yuda Turana
08.30 - 08.40 Discussion
08.40-09.30 Plenary Session
Wiguno Prodjosudjadi
08.40 - 09.05 How to manage hypertension in 2025: International consensus?
George Stergiou (International Society of Hypertension)
09.05 - 09.30 Primordial Hypertension: shaping national health strategies for prevention and management
Teguh Ranakusuma
09.30-10.00 Opening Ceremony
10.00-10.30 Coffee Break
10.30-11.30 Symposium 1
Consequences of Hypertension to the Brain, Heart and Kidney: Strategies to Improve Outcomes
Chair: Lisda Amalia, MD
Symposium 2
Hypertension and Dyslipidemia as a Double Burden of Cerebro Vascular Disease
Chair: Jose Roesma, MD
Symposium 3
Navigating the Complex Relationship: Heart Failure and Cardiorenal Syndrome
Chair: Erwinanto, MD
10:30 - 10:45 (OC) Stroke Prevention in Heart Failure Patients
Rahmat Hidayat
(OC) Genetic Analyses of Lipid Risk Factors for Atherosclerosis
Bambang Purwanto
(OC) Updates on Cardiorenal Continuum
Ria Bandiara
10:45 - 11:00 Tackling HFrEF: Tactics for superior long-term outcomes
Rossana Barack
Updated Pharmacological Approaches to Hypertension Management
Yenny Kandarini
Unlocking Hope Across Heart Failure's Ejection Fractions: Dapagliflozin's Position on Latest Guideline Therapy
Badai Tiksnadi
11:00 - 11:15 ARNI in patients with HFrEF and renal impairment: where do we stand?
Sally A. Nasution
Comprehensive Treatment of Stroke related to Hypertension and Dyslipidemia
Mursyid Bustami
Advancements in Hyperkalemia Management for Cardiorenal Syndrome: New Therapeutic Strategies
Ginnova Nainggolan
11:15 - 11:30 Discussion Discussion Discussion
11.30-12.30 Lunch Symposium 1
JOINT SESSION InaSH - ISH and HOPE ASIA NETWORK
Chair: Anwar Santoso, MD
Lunch Symposium 2
Mastering Hypertension: Innovations and Strategies for Optimal Blood Pressure Control
Chair: Yuda Turana, MD
Lunch Symposium 3
Pioneering Cerebrocardiorenal Complications in Hypertension
Chair: Ekawatidani Yulianti, MD
11:30 - 11:45 Current issues and future perspectives in blood pressure measurement and hypertension diagnosis
George Stergiou (International Society of Hypertension)
Integrative Strategies from the ESH 2024 MASTERplan
Claudio Borghi (European Society of Hypertension)
Guardian of the heart - our superpower in managing all spectrum HF
Siska Suridanda Dany
11:45 - 11:50 Protector of the kidney - easing our CKD patients
Pranawa Martosuwignyo
11:50 - 12:00 Use of angiotensin-receptor neprilysin inhibitor for the management of hypertension
Jiguang Wang (HOPE Asia Network)
Multiple Power on Blood Pressure Control to Prevent Cardio-Renal Complications
Djoko Wibisono
12:00 - 12:10 Tackling the scourge of CVD and CKD with the duo force
Yan Herry
12:10 - 12:15 Discussion Discussion
12:15 - 12:30 Discussion
12.30-13.30 Lunch
13.30-14.30 Symposium 4
ACE Inhibitor and Beta Blocker in the Management of Hypertension
Chair: Ni Made Hustrini, MD
Symposium 5
Exploring Gut Hypertension Axis: Integrating Single Pill Combinations For Optimized CV Management
Chair: Nyoman Paramita Ayu, MD
Symposium 6
Burden of Hypertension to Brain, Heart and Kidney
Chair: Santoso Karo Karo, MD , Co-Chair: Dinda Diafiri, MD
13:30 - 13:45 (OC) Interaction Between the Symphatetic Nervous System and Renin Angiotensin Aldosterone in Hypertension
Zulkhair Ali
(OC) Exploring New Therapeutic Options of Microbiota - Derived Metabolites in Blood Pressure Regulation
Afiatin
(OC) New Insight into Cerebrovascular Pathophysiology in Hypertension
Cep Juli
13:45 - 14:00 Upstream and Downstream Pathway Intervention in controlling Hypertension and Preventing the complication: The Power of ACE-i
Saifur Rohman
Understanding the Link Between TMAO and Cardiovascular Disease: From Pathophysiology to Therapeutic Strategies
Bambang Widyantoro
Optimizing Telmisartan in Managing Hypertension: Beyond Blood Pressure Lowering Effect
Pringgodigdo Nugroho
14:00 - 14:15 The Role of Vasodilator Beta Blocker as Anti Hypertensive Agents in Specific Population (Nebivolol)
Paskariatne Probodewi
Improving Hypertension Treatment and Control: the challenge and how to overcome it with Single Pill Combination
Haerani Rasyid
How to Improve Management of Hypertension Related Proteinuria
Tunggul D. Situmorang
14:15 - 14:30 Discussion Discussion Discussion
14.30-15.30 Symposium 7
The Innovations in Hypertension Monitoring
Chair: Tunggul D. Situmorang, MD
Symposium 8
Evidence to Practice: Renal Denervation as a treatment for Hypertension
Chair: Amanda Tiksnadi, MD
Symposium 9
Management of ASCVD and Type 2 Diabetes
Chair: Yulia Sofiatin, MD
14:30 - 14:45 Machine Learning Models for Early Detection and Diagnosis in Hypertension
I Made Putra Swi Antara
(OC) Recent Update on Resistant Hypertension
Bagus Andi Pramono
(OC) Managing Hypertension in Diabetes: Strategies for Integreted Care and Optimal Outcomes
Rudi Supriyadi
14:45 - 15:00 Cuffless Blood Pressure Monitoring Device for Better Hypertension Control
Hae Young Lee (Korean Society of Hypertension)
The Evidence : The Spyral HTN Clinical program
Faris Basalamah
Managing People with ASCVD and Type 2 Diabetes: What Do Recent Guidelines Say
Antonia Anna Lukito
15:00 - 15:15 The Early Echocardiographic Signs in Hypertensive Heart Disease
BRM Ario Soeryo
Selecting the right patients for Renal Denervation
Maruhum Bonar Marbun
GLP-1 RA Semaglutide Once-Weekly: A Novel Treatment Choice for People with ASCVD and T2D
Dicky Tahapary
15:15 - 15:30 Discussion Discussion Discussion
15.30-15.45 Wrap Up
15.45-16.00 Doorprize

Day 3 : Symposium
Sunday, February 23, 2025

TIME (GMT+7) Ballroom 1 Ballroom 2 Ballroom 3
08.00-09.00 Plenary Session 2
Pringgodigdo Nugroho
08.00 - 08.30 ENVIRONMENTAL CHALLENGES IN MANAGING HYPERTENSION IN INDONESIA: PERSPECTIVE FROM THE POLICY MAKER
Siti Nadia Tarmizi (Ministry of Health, P2PTM)
08.30 - 09.00 PERSPECTIVE OF HYPERTENSION MANAGEMENT IN ASIA
Jiguang Wang (HOPE Asia Network)
09.00-09.30 INASH Award
09.30-10.30 Symposium 10
Hypertension In The Early Age and Pregnancy
Chair: Frits R.W. Suling, MD
Symposium 11
Joint Session InaSH APSH KSH: Obesity, Metabolic Syndrome and Hypertension
Chair: Arieska Ann Soenarta, MD , Co-Chair: Anandhara Indriani K, MD
Symposium 12
Hypertension In Central and Peripheral Vascular Disease
Chair: Afiatin, MD
09:30 - 09:45 Hypertension in Pediatric Populations: Causes, Consequences and Prevention Strategies
Dany Hilmanto
Improving Hypertension control using impedance cardiography
Teo Boon Wee (Asia Pacific Society of Hypertension)
The Effects of Hypertension on Cerebral Autoregulation and Brain Health
Ekawatidani Yulianti
09:45 - 10:00 Hypertension in Adolescent Populations: Strategies for Effective Management
Radityo Prakoso
Long term impact of new-onset diabetes mellitus in hypertensive patients
Hae Young Lee (Korean Society of Hypertension)
Managing Hypertension to Mitigate Dementia Risk and Treatment Strategies
Syahrul Gazali
10:00 - 10:15 Management of hypertension in pregnancy : optimizing maternal and fetal outcomes
Alamsyah
Obesity and Hypertension: Where do Indonesia stand?
Anwar Santoso
Hypertension and Peripheral Arterial Disease
Hananto Andriantoro
10:15 - 10:30 Discussion Discussion Discussion
10.30-11.00 Coffee Break
11.00-12.00 Symposium 13
Secondary Prevention on ASCVD
Chair: Yenny Kandarini, MD
Symposium 14
State of the Art Anti Hypertensive Combination
Chair: Rossana Barack, MD
Symposium 15
CCB: Beyond Blood Pressure Lowering Effect to Atherogenesis
Chair: Eka Musridharta, MD
11:00 - 11:15 (OC) Lipid-Lowering Combination Therapy: What The Guidelines Say?
Bambang Budi Siswanto
Rationale of Anti Hypertensive Combination
Eka Harmeiwaty
Vascular Calcium Channel and High Blood Pressure
Erwinanto
11:15 - 11:30 Intensifying Lipid Management in Stroke Therapy: Current Strategies and Future Directions
Valentinus Besin
How Can We Do Better in Hypertension Management with Fixed Dose Combination
Syafrizal Nasution
The Evolution of CCB as Anti Hypertensive Agent
Aryatama
11:30 - 11:45 The Role of Lipid-Lowering Combination Therapy in Managing Complex Cardiovascular Conditions
Adrianus Kosasih
Targeting Cardiovascular Risk in Hypertension : A Pathway to Better Outcomes
Celly Anantaria
The role of amlodipine in blood pressure control triage: Achieving cardiovascular protection
Ria Bandiara
11:45 - 12:00 Discussion Discussion Discussion
12.00-13.00 Lunch
13.00-14.00 Lunch Symposium 4
ESC 2024 Hypertension Guidelines
Chair: Antonia Anna Lukito, MD
Lunch Symposium 5
Hypertension In Elderly
Chair: Suhardjono, MD , Co-Chair: Tities Anggraeni Indra, MD
Lunch Symposium 6
Hypertension and Chronic Kidney Disease
Chair: Adre Mayza, MD
13:00 - 13:20 What's New on ESC 2024 Guidelines: Introducing Elevated Blood Pressure
Estu Rudiktyo
Hypertension in eldelry : how to to diagnose
Artaria Tjempakasari
The Effects of Hypertension on Renal Blood Flow
Ni Made Hustrini
13:20 - 13:40 Pathophysiology and Clinical Consequeces of Elevated Blood Pressure
Lestariningsih
Updates on Guidelines for the Management of Hypertension in Older People
Yuda Turana
Managing Hypertension in Kidney Transplant Recipient
Endang Susalit
13:40 - 14:00 Discussion Discussion Discussion
14.00-14.30 Wrap Up
14.30-15.00 LAUNCHING InaSH PRACTICAL GUIDE BOOK
15.00-15.30 CLOSING REMARK AND DOOR PRIZE